SMLR

Semler Scientific Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Current Price

$20.33

+0.00%

GoodMoat Value

$128.87

533.9% undervalued

Profile

Valuation (TTM)

Market Cap$300.98M

P/E6.23

EV—

P/B1.30

Shares Out14.80M

P/Sales8.14

Revenue$36.96M

EV/EBITDA6.15

Semler Scientific Inc (SMLR) Valuation

SMLR Fair Value Estimate

$128.87533.9% undervalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

SMLR Valuation Metrics

FCF$24.63M

FCF Growth Rate36.22%

EPS Growth (CAGR)41.88%

WACC10.00%

Fair Value Models

Graham Number, PEG-based, and Earnings-based models

View Fair Value →

SMLR Valuation & Fair Value Analysis

Semler Scientific Inc (SMLR) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for Semler Scientific Inc is $128.87. The current stock price is $20.33, suggesting the stock is 533.9% undervalued.

The price-to-earnings (P/E) ratio is 6.23. Price-to-book ratio is 1.30. Price-to-sales ratio is 8.14. Enterprise value to EBITDA is 6.15. PEG ratio is 0.15.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Semler Scientific Inc's intrinsic value.